Medical Device Network
Abbott’s tissue valves obtain FDA approval for mitral valve replacement
The US Food and Drug Administration (FDA) has approved Abbott’s Epic Plus and Epic Plus Supra Stented Tissue Valves to boost treatment options for individuals with aortic or mitral valve disease.
Stay Up-To-Date on jobs and industry news.
Sign up for the CathLab.com newsletter today!